Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2025 10:00 ET | Source: AscellaHealth, LLC

AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies

AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
July 29, 2025 10:00 ET | Source: AscellaHealth, LLC

AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients

AscellaHealth HUB Partnership with Abeona Therapeutics®
June 17, 2025 06:00 ET | Source: AscellaHealth, LLC

AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025

AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025
May 13, 2025 10:00 ET | Source: AscellaHealth, LLC

AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!

AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
April 29, 2025 10:03 ET | Source: AscellaHealth, LLC

AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®

AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
April 08, 2025 10:00 ET | Source: AscellaHealth, LLC

AscellaHealth Showcases Rare Disease Expertise and Comprehensive Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025

AscellaHealth Highlights Rare Disease Capabilities and End-to-End Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025
April 02, 2025 10:00 ET | Source: AscellaHealth, LLC

AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates

AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates
March 04, 2025 10:00 ET | Source: AscellaHealth, LLC

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

Optime Care has expanded partnership with Eton Pharmaceuticals to serve as the SP provider for GALZIN®, an FDA-approved treatment for Wilson Disease.
February 26, 2025 06:00 ET | Source: AscellaHealth, LLC

AscellaHealth Supports Rare Disease Patients and Caregivers in Observance of Rare Disease Day, February 28

AscellaHealth Commemorates Rare Disease Day, February 28, by Supporting Patients and Caregivers"
February 25, 2025 13:00 ET | Source: AscellaHealth, LLC

AscellaHealth Expands Leadership Team to Accelerate Growth, Strengthen Operations and Advance Patient-Centric Solutions

AscellaHealth announces the appointment of two senior leaders: Clayton Edwards, RPh, MBA and Carl T. Bertram, PharmD, MS, MBA